A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years
This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
- Change from Baseline in Visual Field [ Time Frame: Baseline, 24 Months ] [ Designated as safety issue: No ]
- Change from Baseline in Intraocular Pressure (IOP) [ Time Frame: Baseline, 24 Months ] [ Designated as safety issue: No ]
|Study Start Date:||June 2009|
|Study Completion Date:||May 2013|
|Primary Completion Date:||May 2013 (Final data collection date for primary outcome measure)|
Patients with glaucoma
Other: Standard of Care
Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01629407
|Study Director:||Medical Director||Allergan|